Dermatology Appeals: Biologics and Beyond

If you've worked in dermatology billing for more than five minutes, you know the drill. Patient walks in with severe psoriasis that's failed multiple treatments, your provider recommends a biologic, you submit the prior auth... and bam. Denied. Welcome to the world of dermatology appeals, where persistence pays off and documentation is everything.

Here's the thing though – while biologics grab most of the attention (and for good reason, given their price tags), they're just part of a larger appeals landscape in dermatology. From phototherapy to surgical excisions, understanding how to craft winning appeals can mean the difference between patients getting the care they need and watching them suffer with inadequate treatment.

The Biologics Battle: Your Frontline Strategy

Let's start with the elephant in the room. Biologics like Humira, Stelara, and Cosentyx aren't just expensive – they're really expensive. We're talking $5,000+ per month, which means payers scrutinize every single request with a magnifying glass.

The key to winning biologic appeals isn't just showing that other treatments failed – it's telling the complete story of why this specific patient needs this specific medication right now. I've seen too many appeals that simply state "patient failed methotrexate and topicals." That's not enough anymore.

Instead, paint the picture:

• Document specific previous treatments with exact dates, dosages, and duration


• Include photos showing disease severity (with patient consent, obviously)


• Detail functional impairment – how psoriasis affects their job, relationships, sleep


• Note any contraindications to step therapy requirements

Here's a real example that worked: Instead of writing "patient failed topical steroids," try "Patient used clobetasol 0.05% twice daily for 8 weeks covering 15% BSA with less than 25% improvement in PASI score, and developed skin atrophy on bilateral antecubital fossae, requiring treatment discontinuation."

See the difference? You're not just checking boxes – you're building a case.

Beyond Biologics: The Hidden Appeal Opportunities

While everyone focuses on biologics, some of the easiest wins come from seemingly routine procedures and treatments that get inappropriately denied. I'm talking about things like:

Phototherapy sessions often get cut short by insurance companies who don't understand that 12 sessions might not be enough for someone with extensive vitiligo. Your appeal should include treatment protocols from dermatology societies showing that 24-48 sessions are often necessary.

Surgical excisions get denied when payers don't understand the difference between cosmetic and medical necessity. A seborrheic keratosis might look "just cosmetic" to a nurse reviewer, but if it's irritated by clothing or jewelry, that's medical necessity. Document it.

Mohs surgery denials often stem from location criteria that don't match current guidelines. If you're seeing denials for Mohs on the trunk, your appeal should reference the appropriate use criteria from the American College of Mohs Surgery, not just generic medical policy.

Documentation That Actually Wins Appeals

I can't stress this enough – generic template letters don't work anymore. Payers have gotten smarter, and their medical directors can spot a form letter from a mile away. Your appeals need to be specific, detailed, and clinically compelling.

Start with the patient's story, not the insurance company's denial reason. Yes, you need to address their concerns, but lead with clinical necessity. Something like: "Ms. Johnson is a 34-year-old teacher whose moderate-to-severe plaque psoriasis covering 12% BSA has failed to respond adequately to..."

Then layer in the evidence:

• Clinical photos (when appropriate and consented)


• Quality of life assessments (DLQI scores are gold)


• Functional impairment documentation


• Treatment history with specific dates and outcomes


• Relevant literature supporting your approach

Pro tip: If you're dealing with a condition that has established severity scoring systems (like PASI for psoriasis or SCORAD for atopic dermatitis), use them. Numbers speak louder than subjective descriptions.

Timing and Persistence: When to Fight and When to Pivot

Not every denial is worth appealing – I know that sounds harsh, but hear me out. Sometimes the fastest path to patient care is switching to an alternative that'll get approved quickly, then appealing later for the preferred option.

But when you do appeal, timing matters. Most states give you 180 days, but don't wait. The sooner you get your appeal in, the sooner your patient gets treatment. Plus, details are fresher in everyone's mind.

Here's my rule of thumb for dermatology appeals:

• Immediate appeal: Biologics, Mohs surgery, expensive topicals like Eucrisa


• Consider alternatives first: Generic oral medications with brand name requests


• Strategic delay: Sometimes waiting for more treatment failures actually strengthens your case

And please, don't give up after the first denial. I've seen clear-cut cases get approved on the second or third appeal simply because they landed on the right medical director's desk. Persistence pays off, especially when you're armed with solid documentation.

Some practices are starting to use AI-powered appeal generators to help draft initial letters, which can save time on the basic structure. Just remember – the AI can't replace your clinical knowledge and patient-specific details that make appeals successful.

Moving Forward: Building Your Appeals Toolkit

Look, dermatology appeals aren't going anywhere. If anything, they're getting more complex as new treatments enter the market and payers tighten their criteria. But that doesn't mean you're powerless.

Start building relationships with your most common payers' medical directors. Attend local dermatology society meetings where payer representatives speak. Understanding their perspective makes your appeals more effective.

Keep a database of successful appeal language for common scenarios. When you win an appeal for a specific indication, save that language. You'll use it again.

Most importantly, remember that every appeal is about a real person who's suffering and needs treatment. That human element – when documented properly – is often what tips the scales in your favor. Your persistence in fighting these denials isn't just about revenue; it's about ensuring your patients get the dermatologic care they deserve.